Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical on 20 January 2017 (North American Central Standard Time).
Terumo has acquired the Angio-Seal and FemoSeal vascular closure product lines and Kalila Medical, a company developing next-generation access technologies, the first being the Vado steerable sheath, used in cardiac electrophysiology procedures. The acquisitions enhance company offerings in the interventional access device business.
The acquired assets become part of Terumo Interventional Systems, a division of Terumo Corporation. By building on Terumo’s existing infrastructure and competencies, the acquisition will enable Terumo to maximise the value of the acquired businesses and contribute to supporting safe and efficient interventional procedures.
The financial impact will be included on a consolidated basis, starting with the fourth quarter of the fiscal year ending 31 March 2017. The impact of the acquisition on Terumo’s business performance is being examined. Further details regarding the impact of the acquisition will be disclosed as needed, once the analysis is completed.